比较离子导入经上皮角膜交联与德累斯顿方案治疗进展性圆锥角膜的随机对照试验
前瞻性随机对照试验纳入25例进展性圆锥角膜患者的34眼,随机分为离子导入经上皮角膜交联组(T-ionto CL,22眼)与标准角膜交联组(标准CL,12眼)。12个月时T-ionto CL组最大模拟角膜曲率读数平均平坦-0.52±1.30 D(P=0.06),标准CL组平均平坦-0.82±1.20 D(P=0.04);T-ionto CL组矫正远视力平均改善-0.10±0.12 logMAR(P=0.003),标准CL组为-0.03±0.06 logMAR(P=0.10)。结论认为T-ionto CL术后12个月视力和屈光有显著改善,但角膜地形图读数平均改善略低于同期德累斯顿方案。
要点
- T-ionto CL组12个月Kmax平均平坦-0.52±1.30 D(P=0.06),标准CL组平均平坦-0.82±1.20 D(P=0.04)。
- T-ionto CL组CDVA平均改善-0.10±0.12 logMAR(P=0.003),标准CL组为-0.03±0.06 logMAR(P=0.10)。
- T-ionto CL组无并发症,标准CL组1眼(8%)出现无菌性角膜浸润,未影响最终视力。
核心结论
- T-ionto CL术后12个月视力和屈光有显著改善,但角膜地形图读数平均改善略低于同期德累斯顿方案。
研究设计与样本
- 前瞻性随机对照临床试验,纳入25例进展性圆锥角膜患者的34眼,随机分为T-ionto CL组(22眼)和标准CL组(12眼)。
- T-ionto CL使用离子导入装置、无右旋糖酐的0.1%核黄素-5-磷酸盐溶液(含增强剂),并以10 mW/cm2紫外线A装置照射角膜9分钟。
- 标准CL按德累斯顿方案进行。
主要发现
- 12个月时Kmax在T-ionto CL组平均平坦-0.52±1.30 D(P=0.06),标准CL组平均平坦-0.82±1.20 D(P=0.04)。
- CDVA平均变化在T-ionto CL组为-0.10±0.12 logMAR(P=0.003),标准CL组为-0.03±0.06 logMAR(P=0.10)。
- 显性球镜等效屈光度平均变化在T-ionto CL组为+0.71±1.44 D(P=0.03),标准CL组为+0.21±0.76 D(P=0.38)。
- 12个月时CCT和ECD在任何一组均无显著变化。
- 术后第一周两组间结局指标存在显著差异;T-ionto CL组无并发症,标准CL组1眼(8%)出现无菌性角膜浸润,未影响最终视力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. DESIGN: Prospective randomized controlled clinical trial. PARTICIPANTS: Thirty-four eyes of 25 participants with progressive keratoconus were randomized into T-ionto CL (22 eyes) or standard CL (12 eyes). METHODS: T-ionto CL was performed using an iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by irradiating the cornea with a 10 mW/cm2 ultraviolet A device for 9 minutes. Standard CL was performed according to the Dresden protocol. MAIN OUTCOME MEASURES: The primary outcome measure was stabilization of keratoconus after 12 months through analysis of maximum simulated keratometry readings (Kmax, diopters). Other outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resolution [logMAR]), manifest spherical equivalent refraction (D), central corneal thickness (CCT, micrometers) and endothelial cell density (ECD). Follow-up examinations were arranged at 3 and 7 days and 1, 3, 6, and 12 months. RESULTS: Twelve months after T-ionto CL and standard CL, Kmax on average flattened by -0.52±1.30 D (P = 0.06) and -0.82±1.20 D (P = 0.04), respectively. The mean change in CDVA was -0.10±0.12 logMAR (P = 0.003) and -0.03±0.06 logMAR (P = 0.10) after T-ionto CL and standard CL, respectively. The manifest spherical equivalent refraction changed on average by +0.71±1.44 D (P = 0.03) and +0.21±0.76 D (P = 0.38), respectively. The CCT and ECD measures did not change significantly in any group at 12 months. Significant differences in the outcome measures between treatments were found in the first week postoperatively. No complications occurred in the T-ionto CL group; 1 eye (8%) had sterile corneal infiltrates, which did not affect the final visual acuity, in the standard CL group. CONCLUSIONS: Significant visual and refractive improvements were found 12 months after T-ionto CL, though the average improvement in corneal topography readings was slightly lower than the Dresden protocol in the same period.
引用
- Lombardo M, Giannini D, Lombardo G, et al. Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus. Ophthalmology. 2017. PMID: 28283279. doi:10.1016/j.ophtha.2017.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。